Crescent Capital BDC, Inc. (CCAP) - Q2 2021 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2021. Crescent Capital BDC, Inc. is a Maryland corporation operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The Company invests primarily in secured and unsecured debt and related equity securities of private U.S. middle-market companies. On January 5, 2021, Sun Life Financial Inc. acquired a majority interest in Crescent Capital Group LP, the majority member of the Company's investment adviser.
Key Financial Metrics
| Metric | Q2 2021 (3 Months) | YTD 2021 (6 Months) | YTD 2020 (6 Months) |
|---|---|---|---|
| Total Investment Income | $23.8 million | $44.4 million | $38.2 million |
| Net Investment Income (GAAP) | $11.0 million | $22.4 million | $24.5 million |
| Net Investment Income (Adjusted) | $14.8 million | $27.8 million | $24.5 million |
| Net Realized & Unrealized Gains | $21.8 million | $32.0 million | $(39.1) million |
| Net Increase in Net Assets from Operations | $32.6 million | $54.1 million | $(18.1) million |
| Net Asset Value (NAV) per Share | $20.98 | $20.98 | $18.12 |
| Total Debt (Carrying Value) | $508.8 million | $508.8 million | $471.9 million |
| Cash & Cash Equivalents | $13.0 million | $13.0 million | $1.9 million |
| Portfolio Turnover Ratio | N/A | 17.55% | 15.22% |
Material Changes vs. Prior Period
- Investment Income Growth: Total investment income increased 23% year-over-year for the six months ended June 30, 2021 ($44.4M vs. $38.2M), driven by organic net deployment and higher accelerated accretion of Original Issue Discount (OID).
- Expense Increases: Net expenses increased significantly due to the accrual of capital gains-based incentive fees ($5.4M for YTD 2021 vs. $0 for YTD 2020). This accrual reduced GAAP Net Investment Income despite higher gross income.
- Portfolio Performance: The Company recorded net unrealized appreciation of $27.6 million for the six months ended June 30, 2021, compared to net unrealized depreciation of $37.9 million in the same period in 2020.
- Liquidity: Cash and cash equivalents increased to $13.0 million from $1.9 million at year-end 2020, supported by a net increase in cash from financing activities of $13.0 million.
- Debt Structure: The Company issued $135 million in 2026 Unsecured Notes during the first half of 2021 and repaid all remaining InterNotes obligations.
Guidance, Outlook, and Risks
- Dividend Policy: The Board declared a regular cash dividend of $0.41 per share for the second quarter, payable July 15, 2021. A subsequent dividend of $0.41 per share was declared on August 6, 2021, payable October 15, 2021.
- Fee Waivers: The Adviser has voluntarily waived the income-based portion of the incentive fee through July 31, 2021, and has committed to waiving fees to the extent net investment income falls short of the declared dividend through December 31, 2022.
- Key Risks: The filing highlights risks related to the impact of COVID-19 on portfolio companies, potential defaults, interest rate fluctuations (LIBOR transition), and the illiquidity of private credit investments. The Company holds 14.03% of its assets in non-qualifying investments as of June 30, 2021.
- Non-Accrual Status: As of June 30, 2021, three investment positions in two portfolio companies were on non-accrual status, representing 1.6% of total debt investments at cost.
Investor Verification Checklist
- Capital Gains Incentive Fee Accrual: Verify the impact of the $5.4 million accrued capital gains incentive fee on GAAP Net Investment Income versus Adjusted Net Investment Income ($27.8M).
- Debt Maturity Profile: Review the maturity schedule of the $508.8 million debt portfolio, specifically the $135 million 2026 Unsecured Notes and the $50 million 2023 Unsecured Notes.
- Unfunded Commitments: Note the $126.3 million in unfunded commitments to portfolio companies, which may impact future liquidity requirements.
- Non-Qualifying Assets: Confirm the 14.03% allocation to non-qualifying assets to ensure compliance with BDC regulatory requirements (must maintain 70% qualifying assets).
- Portfolio Concentration: Assess the concentration in the Health Care Equipment & Services sector, which comprised 28.01% of the portfolio fair value.